
4T Medical debuts new syringes
Aesthetics supplier 4T Medical has expanded its Micro Syringe (FMS) range. The company explains that the new additions feature finer needles and shorter lengths, with 33G syringes available in 6mm

Aesthetics supplier 4T Medical has expanded its Micro Syringe (FMS) range. The company explains that the new additions feature finer needles and shorter lengths, with 33G syringes available in 6mm

Scotland’s campaigning trade union General and Municipal Workers’ Union (GMB) has warned that clinics seeking licensing from Healthcare Improvement Scotland (HIS) could face closure due to delays in the application

The Welsh Conservatives have called for greater public awareness of the risks associated with unregulated aesthetic treatments following the successful prosecution of an aesthetics provider by Healthcare Inspectorate Wales (HIW).

The Committee of Advertising Practice (CAP) has published an Enforcement Notice towards advertisements for sunbed use following health and medical claims. The CAP shares that several advertisers have made misleading

The US Food and Drug Administration (FDA) has warned of a potential association between glucagon-like peptide-1 (GLP-1) receptor agonists and nonarteritic anterior ischemic optic neuropathy (NAION), requiring updated warning labels

New market analysis from global market intelligence firm The Business Research Company has highlighted several factors contributing to continued growth within the medical aesthetic energy-based device (EBD) sector. According to

The Association of Dentists in Aesthetic Practice (ADAP) is publishing its first Education and Competency Framework for dentists working in medical aesthetics. Led by aesthetic practitioner Dr Rehanna Beckhurst, chair

The Joint Council for Cosmetic Practitioners (JCCP) has appointed aesthetic practitioner Dr Natasha Verma as chair for the Education and Training Committee. The JCCP shares that Dr Verma brings extensive experience

Aesthetic distributor ES Aesthetic Solutions debuted NouVys, a collagen-peptide injectable, to the UK market. According to the company, NouVys combines low molecular weight collagen peptides with Magnesium Ascorbyl Phosphate (MAP),

Pharmaceutical company Galderma has announced that China’s National Medical Products Administration (NPA) has approved Relfydess (relabotulinumtoxinA) for the temporary improvement of moderate-to-severe glabellar lines in adults. The approval is supported